Autres langues Beijing Beilu Pharmaceutical Co., Ltd.

Actions

300016

CNE000001QK9

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 02/09/2026			Varia. 5j.	Varia. 1 janv.
8,600 ^CNY	-1,83%		-9,19%	+8,31%

25/08	Beijing Beilu Pharmaceutical Co., Ltd. propose un dividende intérimaire en numéraire pour 2026	CI
24/08	Beijing Beilu Pharmaceutical Co., Ltd. publie ses résultats pour le premier semestre clos le 30 juin 2026	CI

Autres langues

25/08	Beijing Beilu Pharmaceutical Co., Ltd. Proposes Interim Cash Dividend for 2026
24/08	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
28/04	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
27/04	Beijing Beilu Pharmaceutical Co., Ltd. announced that it has received CNY 159 million in funding from a group of investors
21/04	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
28/10/25	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
03/09/25	Beijing Beilu Pharmaceutical Subsidiary Gets License to Enter Brazilian Market
25/08/25	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
22/07/25	Beijing Beilu Pharmaceutical Gets India Nod for Angiogram Constrasting Agent
10/06/25	Beijing Beilu Pharmaceutical Co., Ltd Announces Executive Changes
09/05/25	Beijing Beilu Pharmaceutical Co., Ltd Approves Cash Dividend on A Shares for the Year 2024, Payable on 19 May 2025
08/05/25	Beijing Beilu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 300 million in funding
24/04/25	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
18/04/25	Beijing Beilu Pharmaceutical Co., Ltd Proposes Final Cash Dividend for 2024
17/04/25	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
03/03/25	Sanxia Paints to Sell Stake in Beilu Pharma
13/01/25	Beijing Beilu Pharmaceutical Seeks Bank Loan with Subsidiary's Equity as Collateral
29/10/24	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
27/08/24	Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2024
21/04/24	Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
29/02/24	Beijing Beilu Pharmaceutical Co., Ltd Signed a Letter of intent to acquire 80% stake in Chengde Tianyuan Pharmaceuticals Co.,Ltd from Goldenmax International Group Ltd. for CNY 248 million.
26/10/23	Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
27/08/23	Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
18/05/23	Beijing Beilu Pharmaceutical Co., Ltd Announces Cash Dividend on A Shares for 2022, Payable on May 25, 2023
17/05/23	Beijing Beilu Pharmaceutical Co., Ltd Approves Cash Dividend for 2022